NERVGEN PHARMA CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.33 CAD | +7.87% |
|
+10.43% | -13.70% |
| 04-17 | NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update | MT |
| 04-17 | NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar NervGen Pharma Corp.
8a7f360e5386bdbbaaaff8d886495a.3VSk2eve27fJtGfsNryXFVczpumdprV4a2qigyqFLW0.iTjjiZ-JnMaO3BakDvb_YwMA7I7c89EWGyWW2mzPbiCyGP30qLCa4qr1Vw~ddd0573f1e43931bb56533bede22a9bd
Upcoming events on NervGen Pharma Corp.
Past events on NervGen Pharma Corp.
| 17/04/2024 13:32 | Q4 2023 Earnings Release |
| 09/11/2023 13:30 | Q3 2023 Earnings Release |
| 14/09/2023 15:10 | International Spinal Research Trust Network Meeting |
| 13/09/2023 21:00 | H.C. Wainwright Global Investment Conference |
| 11/09/2023 | Investor Meeting |
| 24/08/2023 16:00 | Investor Meeting - Key Opinion Leader |
| 09/08/2023 13:30 | Q2 2023 Earnings Release |
| 22/06/2023 16:30 | OTC Life Science Investor Forum |
| 17/05/2023 21:00 | Annual General Meeting |
| 15/05/2023 13:01 | Q1 2023 Earnings Release |
| 16/04/2023 | American Spinal Injury Association Scientific Meeting |
| 30/03/2023 13:30 | Q4 2022 Earnings Release |
| 14/11/2022 13:03 | Q3 2022 Earnings Release |
| 25/10/2022 | European Committee for Treatment and Research in Multiple Sclerosis Congress |
| 21/10/2022 | American Neurological Association Meeting |
| 28/09/2022 18:00 | Annual General Meeting |
| 16/09/2022 | International Spinal Cord Society Scientific Meeting |
| 11/09/2022 | Military Health System Research Symposium |
| 10/08/2022 13:03 | Interim 2022 Earnings Release |
| 19/05/2022 12:20 | International Investment Forum |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | 0,00 | -8,75 -9,90 11.59% | -20,1 -19,0 -5.97% | -11,6 | -21,6 |
|
EBIT Million CAD | Released Forecast Spread | 0,00 | -12,8 -11,6 -10.92% | -23,0 -24,7 6.78% | 0,00 | 0,00 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
Net income Million CAD | Released Forecast Spread | -11,2 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EPS CAD | Released Forecast Spread | -0,35 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
| Announcement Date | 08/04/21 | 28/02/22 | 30/03/23 | 17/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |||||
|
EBITDA Million CAD | Released Forecast Spread | -3,06 -2,40 -27.46% | -4,20 -2,60 -61.38% | -5,45 -4,00 -36.19% | -4,28 -5,70 24.92% | -6,21 -5,10 -21.81% | -4,50 | -6,20 | -5,60 | -5,30 |
|
EBIT Million CAD | Released Forecast Spread | -4,15 -3,50 -18.47% | -5,00 -3,60 -39.01% | -6,31 -5,00 -26.26% | -4,92 -6,80 27.59% | -6,78 -6,20 -9.42% | ||||
| Announcement Date | 28/02/22 | 12/05/22 | 10/08/22 | 14/11/22 | 30/03/23 | - | - | - | - |
More events
Past sector events for NervGen Pharma Corp.
| 02/05/2024 21:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 13:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- NGEN Stock
- Calendar NervGen Pharma Corp.
